TalkRadio Interview17 Apr 2020 10:42
Avacta TalkRadio
CEO interview
What test are you looking at? Anitgen or Antibody?
Key point, this is a test for the antigent, equivalent to the type of PCR testing, where many countries are struggling from a capacity testing
PCR is nasal swab that is sent to the lab
we are trying to deliver a different way to detect the antigena and provide a saliva based test
This can take place in a car park?
Absolutely, in principle it can be provided direct to consumers (regulatory hurdles) but it is a test strip in the same was as how a pregnancy test
is done on a test strip, only in this case with saliva
How far down the road are you? How reliable and scale?
In order to detect the antigen, you need a regagent that will detect the viral particle (e.g. spikes on the outside of the virus)
it takes time to develop those new reagents, typically that takes many months
we have a technology that we have developed over a number of years, called the affirmer, is a very rapid way of developing reagents to detect new pathogens
we can do this in a few weeks vs a few months, we are in the middle of that process and in 2-3 weeks we will know if we have successfully developed a reagent
in a further 2-3 weeks, we will know if we have a test that will work
Mass scale?
So those affirmers and reagents can be put onto a range of test strips, such as pregnancy / lateral flow - that is the subject of our partnership with
Cytiva AKA GE Healthcare, equally the type of test could also be put onto hosptial high througput platforms
Sign In
Follow the stocks
